Trupanion (NASDAQ:TRUP) Shares Up 10.5%

→ The CHIPS Act Motherlode (From True Market Insiders) (Ad)

Trupanion, Inc. (NASDAQ:TRUP - Get Free Report) was up 10.5% during trading on Monday . The company traded as high as $22.80 and last traded at $21.93. Approximately 346,862 shares traded hands during trading, a decline of 49% from the average daily volume of 677,940 shares. The stock had previously closed at $19.85.

Analyst Ratings Changes

A number of equities research analysts have recently weighed in on the stock. Canaccord Genuity Group lowered their price objective on shares of Trupanion from $40.00 to $34.00 and set a "buy" rating for the company in a report on Friday. Evercore ISI lowered their price target on shares of Trupanion from $35.00 to $31.00 and set an "outperform" rating for the company in a research note on Tuesday, February 20th. Stifel Nicolaus raised their price objective on Trupanion from $25.00 to $28.00 and gave the company a "hold" rating in a research note on Friday, February 16th. Finally, Piper Sandler lowered their target price on Trupanion from $28.00 to $22.00 and set a "neutral" rating for the company in a research note on Friday. Four analysts have rated the stock with a hold rating and two have given a buy rating to the stock. According to data from MarketBeat, Trupanion has a consensus rating of "Hold" and a consensus price target of $29.40.

View Our Latest Stock Report on Trupanion

Trupanion Stock Up 13.4 %

The firm has a market cap of $945.19 million, a PE ratio of -35.17 and a beta of 1.76. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.63 and a current ratio of 1.62. The company's 50-day simple moving average is $25.58 and its two-hundred day simple moving average is $26.70.


Trupanion (NASDAQ:TRUP - Get Free Report) last posted its earnings results on Thursday, May 2nd. The financial services provider reported ($0.16) earnings per share for the quarter, topping analysts' consensus estimates of ($0.18) by $0.02. Trupanion had a negative net margin of 2.31% and a negative return on equity of 9.03%. The company had revenue of $306.12 million during the quarter, compared to analyst estimates of $300.51 million. During the same period in the prior year, the business posted ($0.60) earnings per share. Trupanion's revenue for the quarter was up 19.4% on a year-over-year basis. On average, analysts predict that Trupanion, Inc. will post -0.43 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Trupanion

A number of institutional investors and hedge funds have recently modified their holdings of the company. Sivia Capital Partners LLC bought a new position in Trupanion in the fourth quarter worth approximately $31,398,000. 8 Knots Management LLC bought a new position in Trupanion in the 4th quarter worth $21,165,000. Wellington Management Group LLP lifted its position in Trupanion by 34.6% during the fourth quarter. Wellington Management Group LLP now owns 2,453,685 shares of the financial services provider's stock valued at $74,862,000 after purchasing an additional 630,155 shares in the last quarter. Tudor Investment Corp Et Al bought a new stake in Trupanion during the third quarter valued at about $4,712,000. Finally, GSA Capital Partners LLP increased its position in Trupanion by 376.5% in the first quarter. GSA Capital Partners LLP now owns 80,046 shares of the financial services provider's stock worth $2,210,000 after buying an additional 63,247 shares in the last quarter.

Trupanion Company Profile

(Get Free Report)

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.

Featured Articles

→ The CHIPS Act Motherlode (From True Market Insiders) (Ad)

Should you invest $1,000 in Trupanion right now?

Before you consider Trupanion, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Trupanion wasn't on the list.

While Trupanion currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Featured Articles and Offers

Search Headlines: